HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Sodium Chloride → 4-(dimethylamino)-4-phenyl-1-(3-(3-(tetrahydro-2H-pyran-2-yloxy)propyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)cyclohexanol

HRID 1095598
Print

Reaction equation

HRID 1095598 reaction equation
[CH3:1][N:2]([CH3:28])[C:3]1([C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=2)[CH2:8][CH2:7][C:6]([C:10]#[C:11][CH2:12][CH2:13][CH2:14][O:15][CH:16]2[CH2:21][CH2:20][CH2:19][CH2:18][O:17]2)([OH:9])[CH2:5][CH2:4]1.[NH2:29][C:30]1[C:35](I)=[CH:34][CH:33]=[CH:32][N:31]=1.[Cl-].[Li+].C(=O)([O-])[O-].[Na+].[Na+].[Cl-].[Na+]>CN(C)C=O.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2].C(Cl)Cl.O>[CH3:28][N:2]([CH3:1])[C:3]1([C:22]2[CH:23]=[CH:24][CH:25]=[CH:26][CH:27]=2)[CH2:4][CH2:5][C:6]([C:10]2[NH:29][C:30]3=[N:31][CH:32]=[CH:33][CH:34]=[C:35]3[C:11]=2[CH2:12][CH2:13][CH2:14][O:15][CH:16]2[CH2:21][CH2:20][CH2:19][CH2:18][O:17]2)([OH:9])[CH2:7][CH2:8]1
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

10

Reactant 5

HCID 5234Sodium ChlorideHCID 10340Sodium CarbonateHCID 433294Lithium ChlorideHCID 27631512-Amino-3-iodopyridineHCID 574751824-(Dimethylamino)-4-phenyl-1-(5-(tetrahydro-2H-pyran-2-yloxy)pent-1-ynyl)cyclohexanol

Product 1

HCID 57475183
4-(dimethylamino)-4-phenyl-1-(3-(3-(tetrahydro-2H-pyran-2-yloxy)propyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)cyclohexanol
Yield 28%

Reagents, catalysts & solvents 4

HCID 44119782Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+)CatalystHCID 962WaterSolventHCID 6228DimethylformamideSolventHCID 6344DichloromethaneSolvent2×

Conditions

Temperature
105 °C

Procedure

4-(Dimethylamino)-4-phenyl-1-(5-(tetrahydro-2H-pyran-2-yloxy)pent-1-ynyl)cyclohexanol (700 mg, 1.82 mmol), 2-amino-3-iodopyridine (363 mg, 1.65 mmol), lithium chloride (74 mg, 1.73 mmol) and sodium carbonate (525 mg, 4.95 mmol) was dissolved in dimethylformamide (20 ml) under an argon atmosphere. Argon was subsequently allowed to flow through the solution for 10 min and the catalyst ([Pd(dppf)Cl2×CH2Cl2], 135 mg, 0.17 mmol) was then added. The reaction mixture was heated at 105° C. (oil bath temperature) for 3 h. A TLC showed that the starting substances had been used up completely. The black reaction mixture was cooled to room temperature and water (50 ml; stirring for 10 min), methylene chloride (50 ml) and saturated sodium chloride solution (for phase separation, 80 ml) were added in succession. The phases were separated and the aqueous phase was extracted with methylene chloride (3×20 ml). The combined organic phases were washed with water (20 ml) and with saturated sodium chloride solution (3×20 ml), dried over sodium sulfate and filtered and the volatile constituents were then removed completely in vacuo. The residue was separated by chromatography [silica gel 60 (200 g); chloroform/ethanol 19:1 (500 ml), 9:1 (500 ml), 4:1 (500 ml), methanol (1,000 ml)]. It was possible to obtain a diastereoisomer of the alcohol (4-(dimethylamino)-4-phenyl-1-(3-(3-(tetrahydro-2H-pyran-2-yloxy)propyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)cyclohexanol) (m.p.: 238° C.) in a yield of 28% (221 mg, 0.46 mmol) as a white powder.

Workup

  1. customThe black reaction mixture
  2. temperaturewas cooled to room temperature
  3. customThe phases were separated
  4. extractionthe aqueous phase was extracted with methylene chloride (3×20 ml)
  5. washThe combined organic phases were washed with water (20 ml) and with saturated sodium chloride solution (3×20 ml)
  6. dry with materialdried over sodium sulfate
  7. filtrationfiltered
  8. customthe volatile constituents were then removed completely in vacuo
  9. customThe residue was separated by chromatography [silica gel 60 (200 g); chloroform/ethanol 19:1 (500 ml), 9:1 (500 ml), 4:1 (500 ml), methanol (1,000 ml)]

Sources & evidence

ORD record
ord-93b958b1e41240999af54b7976e830c9
Source dataset
uspto-grants-2012_03
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08138187B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes